BioSpace News Archive

Virios Therapeutics, Inc. today announced that it will report first quarter 2023 financial results on Thursday, May 11, 2023 before the open of the financial markets.

Agios Pharmaceuticals, Inc. today reported business highlights and financial results for the first quarter ended March 31, 2023.

BioRestorative Therapies, Inc. today announced that CEO Lance Alstodt will participate at the Inaugural EF Hutton Global Conference taking place May 10th to 11th at the Plaza Hotel in New York City.

Passage Bio, Inc. has announced Nicolette “Nikki” Evich, a sophomore at The Schreyer Honors College at The Pennsylvania State University, as the second recipient of its Tachi Yamada Scholarship award.

Omega Therapeutics today announced financial results for the first quarter ended March 31, 2023, and highlighted recent Company progress.

Chimerix today reported financial results for the first quarter ended March 31, 2023 and provided an operational update.

XORTX Therapeutics Inc. is pleased to announce completion of a positive and constructive Type D meeting with the U.S. Food and Drug Administration (“FDA”) which resulted in the identification of additional clinical endpoints potentially available for accelerated approval and further understanding of the FDA expectations for the accelerated approval of XORLO™ for the treatment of autosomal dominant polycystic kidney disease (“ADPKD”).

Xtant Medical Holdings, Inc. today reported financial and operating results for the first quarter ended March 31, 2023.

HOOKIPA Pharma Inc. today announced that HOOKIPA’s management team will participate in and present at the following upcoming investor conferences.

iSpecimen Inc. today reported its financial and operating results for the three-month period ended March 31, 2023.